EJW treatment reduced these levels (Figures 14D–F), suggesting EJW may mitigate AGEs/RAGE/NF-κB signaling pathway activation, enhancing lipid metabolism and thereby exerting a therapeutic effect on AD. This evidence concerns the gene AGER and Alzheimer disease.